Europe
Galapagos NV announced that its board of directors created 2,070,000 warrants under new warrant plans for the benefit of the employees, directors, and a consultant of the company and its subsidiaries.
Combining genetic and biochemical testing to provide the most comprehensive screening for rare metabolic conditions
EXNER’s new generation of the EXcell sensor series not only provides the end user with higher flexibility during application, but at the same time allows safer processing.
MorphoSys AG will present at the following conferences
Getinge’s Maquet PowerLED II Surgical Light brings best in class technology to general and Hybrid OR’s by improving surgical efficiency for surgeons and staff.
Pharma and biotech companies from Asia to Europe provide updates on business and clinical activities.
With the ever-rising concerns over the costs of various prescription medications, a report from consumer pharmaceutical watchdog group Institute for Clinical and Economic Review released a report questioning the potential pricing of two yet-to-be-approved peanut allergy treatments.
The French drugmaker expanded its one-year-old Valyou Savings Program to lower the cost of up to 10 boxes of pens and 10 boxes of vials to $99 per month.
Polyphor AG, a clinical stage, Swiss biopharmaceutical company focused on the discovery and development of antibiotics and immuno-oncology compounds announced the appointment of Gökhan Batur to the newly created position of Chief Commercial Officer.
Alcon CEO says the company is “poised to achieve sustainable growth and create long-term shareholder value as a standalone company.”
PRESS RELEASES